GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Market Cap

Giant Biogene Holding Co (HKSE:02367) Market Cap : HK$51,656 Mil (As of Jun. 07, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Giant Biogene Holding Co's share price for the quarter that ended in Dec. 2023 was HK$35.6. Giant Biogene Holding Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 982 Mil. Therefore, Giant Biogene Holding Co's market cap for the quarter that ended in Dec. 2023 was HK$34,946 Mil.

Giant Biogene Holding Co's quarterly market cap increased from Dec. 2022 (HK$33,432 Mil) to Jun. 2023 (HK$34,626 Mil) and increased from Jun. 2023 (HK$34,626 Mil) to Dec. 2023 (HK$34,946 Mil).

Giant Biogene Holding Co's annual market cap increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$33,432 Mil) and increased from Dec. 2022 (HK$33,432 Mil) to Dec. 2023 (HK$34,946 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Giant Biogene Holding Co's Enterprise Value for Today is HK$48,418 Mil.


Giant Biogene Holding Co Market Cap Historical Data

The historical data trend for Giant Biogene Holding Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Market Cap Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 33,432.00 34,946.31

Giant Biogene Holding Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial - - 33,432.00 34,626.00 34,946.31

Competitive Comparison of Giant Biogene Holding Co's Market Cap

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co's Market Cap Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Market Cap falls into.



Giant Biogene Holding Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Giant Biogene Holding Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$35.6*981.638
=HK$34,946

Giant Biogene Holding Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=HK$35.6*981.638
=HK$34,946

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Giant Biogene Holding Co  (HKSE:02367) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Giant Biogene Holding Co Market Cap Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Giant Biogene Holding Co (HKSE:02367) Business Description

Traded in Other Exchanges
N/A
Address
No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Executives
Refulgence Holding Limited 2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd 2101 Beneficial owner
Fan Daidi 2201 Interest of corporation controlled by you
Yan Jianya 2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Yan Jianya 2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited 2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines